Evidence map›Paper›PMID 29900200›Full record

ArticleData in brief2018

Data of the effects of acetone fraction from

Celeste Trejo-Moreno, Gabriela Castro-Martínez, Marisol Méndez-Martínez, Jesús Enrique Jiménez-Ferrer, José Pedraza-Chaverri, Gerardo Arrellín, Alejandro Zamilpa-Álvarez, Omar Noel Medina-Campos, Galia Lombardo-Earl, Gerardo Joel Barrita-Cruz and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Data in brief, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Celeste Trejo-MorenoFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos CP 62350, Mexico.
Gabriela Castro-MartínezFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos CP 62350, Mexico.
Marisol Méndez-MartínezFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos CP 62350, Mexico.
Jesús Enrique Jiménez-FerrerLaboratorio de Farmacología, Centro de Investigaciones Biomédicas del Sur, Instituto Mexicano del Seguro Social, Xochitepec, Morelos CP 62790, Mexico.
José Pedraza-ChaverriFacultad de Química, Universidad Autónoma de México, Coyoacán, Ciudad de México CP 04510, Mexico.
Gerardo ArrellínFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos CP 62350, Mexico.
Alejandro Zamilpa-ÁlvarezLaboratorio de Farmacología, Centro de Investigaciones Biomédicas del Sur, Instituto Mexicano del Seguro Social, Xochitepec, Morelos CP 62790, Mexico.
Omar Noel Medina-CamposFacultad de Química, Universidad Autónoma de México, Coyoacán, Ciudad de México CP 04510, Mexico.
Galia Lombardo-EarlLaboratorio de Farmacología, Centro de Investigaciones Biomédicas del Sur, Instituto Mexicano del Seguro Social, Xochitepec, Morelos CP 62790, Mexico.
Gerardo Joel Barrita-CruzFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos CP 62350, Mexico.
Beatriz HernándezFacultad de Medicina, Universidad Nacional Autónoma de México, Coyoacán, Ciudad de México CP 04510, Mexico.
Christian Carlos RamírezFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos CP 62350, Mexico.
María Angélica SantanaCentro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Chamilpa, Cuernavaca, Morelos CP 62209, Mexico.
Gladis FragosoInstituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Coyoacán, Ciudad de México CP 04510, Mexico.
Gabriela RosasFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos CP 62350, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial dysfunction induced by Angiotensin II (AG II) plays an important role in the pathogenesis of hypertension and is accompanied by a prooxidative condition, which in turn induces an inflammatory state, vascular remodeling, and tissue damage including the kidney (Schmitt and Dirsch, 2009) [1]. New drugs that can control several of these pathologies are required.

Identifiers

PMID29900200
PMCPMC5996300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.